Hamoir, C <br/><br/>
Hepatobiliary and Pancreatic: Nivolumab-related cholangiopathy.  [electronic resource] 

 -  Journal of gastroenterology and hepatology  Oct 2018 
 - 1695 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1440-1746 
<br/><br/><label>Standard No.: </label>10.1111/jgh.14136  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents, Immunological--adverse effects<br/>Bile Ducts, Intrahepatic--diagnostic imaging<br/>Carcinoma, Non-Small-Cell Lung--therapy<br/>Cholangiopancreatography, Magnetic Resonance<br/>Cholangitis--chemically induced<br/>Humans<br/>Immunotherapy--adverse effects<br/>Lung Neoplasms--therapy<br/>Male<br/>Nivolumab--adverse effects